Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 11, pp. 1888-1895
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect
Zahra Merali, Stephanie Ross, Guillaume Paré
Drug metabolism and drug interactions (2014) Vol. 29, Iss. 3, pp. 143-151
Closed Access | Times Cited: 88
Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
Haruka Nishimuta, J. Brian Houston, Aleksandra Galetin
Drug Metabolism and Disposition (2014) Vol. 42, Iss. 9, pp. 1522-1531
Closed Access | Times Cited: 71
Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption
Alfred C. F. Rumondor, Sundeep S. Dhareshwar, Filippos Kesisoglou
Journal of Pharmaceutical Sciences (2016) Vol. 105, Iss. 9, pp. 2498-2508
Closed Access | Times Cited: 66
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice
Wen-juan Hu, Lu Chang, Ying Yang, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 7, pp. 1195-1200
Open Access | Times Cited: 56
Human carboxylesterases and fluorescent probes to image their activity in live cells
Anchal Singh, Mingze Gao, Michael Beck
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1142-1153
Open Access | Times Cited: 35
Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth
Keun Na, Minjoo Kim, Chae-Yeon Kim, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 12, pp. 4867-4883
Closed Access | Times Cited: 29
Sequential liquid-liquid extraction coupled to LC-MS/MS for simultaneous determination of amlodipine, olmesartan and hydrochlorothiazide in plasma samples: Application to pharmacokinetic studies
Ehab F. Elkady, Asmaa A. Mandour, Faisal K. Algethami, et al.
Microchemical Journal (2020) Vol. 155, pp. 104757-104757
Closed Access | Times Cited: 25
p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP
Yingdan Huang, Xiong Chen, Chunmeng Wang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113426-113426
Open Access | Times Cited: 8
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil
Masae Sekido, Ken‐ichi Fujita, Yutaro Kubota, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 83, Iss. 6, pp. 1127-1135
Closed Access | Times Cited: 18
Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male Subjects
Hyerang Roh, Hankil Son, Dong Hwan Lee, et al.
Clinical Therapeutics (2014) Vol. 36, Iss. 8, pp. 1159-1170
Closed Access | Times Cited: 15
Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir
Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 9, pp. 4176-4188
Closed Access | Times Cited: 13
Bioinformatic profiling identifies a platinum‐resistant–related risk signature for ovarian cancer
Ce Wu, Linxiu He, Qian Wei, et al.
Cancer Medicine (2019) Vol. 9, Iss. 3, pp. 1242-1253
Open Access | Times Cited: 11
Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia
Kohnosuke Kinoshita, Motoki Ochi, Katsuya Iwata, et al.
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 5
Open Access | Times Cited: 10
Human Intestinal Raf Kinase Inhibitor Protein (RKIP) Catalyzes Prasugrel as a Bioactivation Hydrolase
Miho Kazui, Yuji Ogura, Katsunobu Hagihara, et al.
Drug Metabolism and Disposition (2015) Vol. 44, Iss. 1, pp. 115-123
Open Access | Times Cited: 9
Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine?
S. Casey Laizure, Robert B. Parker
Xenobiotica (2019) Vol. 50, Iss. 1, pp. 92-100
Closed Access | Times Cited: 9
Deciphering the species differences in CES1A-mediated hydrolytic metabolism by using a bioluminescence substrate
Qiang Jin, Zan Li, Mengjie Zhang, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110197-110197
Closed Access | Times Cited: 4
Design, synthesis and characterizations of prodrugs of brexanolone
Lianhong Xu, Ji Ma, Leifeng Shi, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 90, pp. 129344-129344
Closed Access | Times Cited: 2
A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
Jeanne Mendell, Nobuko Matsushima, Terry O’Reilly, et al.
The Journal of Clinical Pharmacology (2015) Vol. 56, Iss. 4, pp. 484-491
Open Access | Times Cited: 4
Evaluation of anti-inflammatory, immunomodulatory effects and celiac-like side effect of olmesartan medoxomil as a vitamin D receptor agonist and angiotensin II receptor blocker
Yelda Komesli, H. Yeşim Karasulu
Journal of Research in Pharmacy (2021) Vol. 26(1), Iss. 26(1), pp. 1080-1091
Open Access | Times Cited: 4
A Novel Systematic Approach for Selection of Prodrugs Designed to Improve Oral Absorption
Mai Shimizu, Tatsuki Fukami, Toshio Taniguchi, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 109, Iss. 5, pp. 1736-1746
Closed Access | Times Cited: 3
In Vitro Hepatic Metabolism of Curcumin Diethyl Disuccinate by Liver S9 from Different Animal Species
Ponsiree Jithavech, Pahweenvaj Ratnatilaka Na Bhuket, Wiwat Supasena, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 3
Development of a Triphenylmethyl Alkylation Pre-Column Derivatization Method for HPLC Quantitative Analysis of Chemically Unstable Halogenated Compounds
Jianwu Lu, Yinfei Shi, Xiaoxia Ye, et al.
ACS Omega (2024) Vol. 9, Iss. 13, pp. 15311-15319
Open Access
Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro
Liang Jia-hong, Xiao-Lei Yi, Jia-Min Gong, et al.
Toxicology in Vitro (2024) Vol. 98, pp. 105833-105833
Closed Access
Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature Review
Karl‐Uwe Petersen, Wolfgang A. Schmalix, Marija Pesic, et al.
Current Drug Metabolism (2024) Vol. 25, Iss. 6, pp. 431-445
Closed Access
Renin-Angiotensin-Aldosterone System
Robert C. Speth
Elsevier eBooks (2021), pp. 528-569
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top